Factor VIIa Concept

Vocabulary Service

MeSH

Overview

subject area of

A therapeutic alternative for haemophiliacs with inhibitors Journal Articles
Age‐related changes in factor VII proteolysis in vivo Journal Articles
Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery Journal Articles
An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency Journal Articles
Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism Journal Articles
Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age? Journal Articles
Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery Journal Articles
Continuous Infusion of Recombinant Factor VIIa in Hemophilic Patients with Inhibitors: Safety, Monitoring, and Cost Effectiveness Journal Articles
Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII Journal Articles
D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy Journal Articles
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Journal Articles
Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement Journal Articles
Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA. Journal Articles
Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: An individual patient based meta-analysis of two controlled trials Journal Articles
Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Journal Articles
Experiences with continuous infusion of recombinant activated factor VII. Conferences
Factor VIIa gets even bigger Journal Articles
Feasibility of Using Recombinant Factor VIIa in Continuous Infusion Journal Articles
How I treat target-specific oral anticoagulant–associated bleeding Journal Articles
Iatrogenic causes of an ICH Journal Articles
Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates Journal Articles
Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns Journal Articles
LETTERS TO THE EDITOR Journal Articles
Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia Journal Articles
Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists Journal Articles
Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa Journal Articles
Neutralization of Heparin Activity Journal Articles
New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management Conferences
New Anticoagulant Therapy Journal Articles
Novel platelet products, substitutes and alternatives Journal Articles
Novel treatment modalities: new platelet preparations and subsititutes Journal Articles
Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report) Journal Articles
On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers Journal Articles
Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care Journal Articles
Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivo Journal Articles
Recombinant FVIIa in children with liver disease Journal Articles
Recombinant Factor VIIa in Multiple Surgery Journal Articles
Recombinant activated factor VII for the treatment of life-threatening haemorrhage Journal Articles
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding Journal Articles
Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors Journal Articles
Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies Journal Articles
Reversing Anticoagulant Therapy Journal Articles
Reversing anticoagulants both old and new. Journal Articles
Review of pumps for continuous infusion of coagulation factor concentrates: what are the options? Conferences
SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY Journal Articles
Safety, efficacy and lessons from continuous infusion with rFVIIa Conferences
Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group. Journal Articles
Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves Journal Articles
The M358R variant of α 1 -proteinase inhibitor inhibits coagulation factor VIIa Journal Articles
The onerous task of comparing treatments in inhibitor patients Journal Articles
The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference Journal Articles
Thrombin generation in vitro in the presence of by‐passing agents in siblings with severe haemophilia A Journal Articles
Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial Journal Articles
Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia Journal Articles
We Need Both Evidence and Values to Navigate Uncertainty Journal Articles
What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin? Journal Articles
Zinc: An important cofactor in haemostasis and thrombosis Journal Articles